InvestorsHub Logo
Followers 2
Posts 286
Boards Moderated 0
Alias Born 01/25/2017

Re: None

Saturday, 05/13/2017 8:07:27 AM

Saturday, May 13, 2017 8:07:27 AM

Post# of 211609
Seems a few posters feel that the stock is doomed because there is a disconnect between the stack price and the company's performance. Will address that but first, my prediction for Q1 revenues:

Less than $1 million (under 17,000 cases sold) would be a disappointment.

$1-$2 million would meet expectations (17,000-33,000 cases sold).

Over $2 million would exceed expectations (more than 33,000 cases sold).

My feeling is that revenues will fall between $1-$2 million for Q1.

As to the stock price, there are a couple of ways to address that if (with no changes in current share structure or company ownership) it continues in the 0.01-0.02 range:

1. As soon as cash flow exceeds the minimum needed to purchase inventory and the debt is paid off, announce a share buy back and then do so.

2. Uplist

3. Market the company to a suitor for a buyout

#2 and #3 IMO are so likely I'd say they're almost inevitable. Given the company officers not taking a salary and owning a lot of shares, CB with the right to buy 1% of shares at 0.001...they have a significant interest to increase the share price (remember her photo with a certain large beverage company name in the background...doesn't mean it will happen but does document the mindset). Also, the company has already announced they have hired a consultant to evaluate buyout possibilities.

A reverse split and/or increasing the number of shares by billions...a scenario postulated by some individuals (who have also indicated they are shorting ICNB :)) would be counterintuitive to what the primary players (Rich, CB, Joe) want because it would free fall the share price. Therefore, IMO it is highly unlikely.

The share buyback possibilities may be limited by cash flow and the increase in the price of the stock ;)

My main concern now with the rollout progressing and large retailer/international coming is that the buyout will occur at a disappointingly low price, for example 0.10-0.30.

As a basis of comparison, Prisoner Wine sold for $285 million after being grown to 170,000 cases sold/year.
http://www.winespectator.com/webfeature/show/id/52992

That would be about 0.33 a share for ICNB with current O/S of 866 million. I and other longs are hoping for $1/share plus...still doable with the full international rollout and then buyout in late 2018 IMO.

170,000 cases sold annually is less than 15,000 cases a month and IMO there is a 50/50 chance Bellissima hits that mark or exceeds it for 2017, particularly since Q2 and beyond will include CA sales, as well as potentially a large chain and some international later in the year. GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICNB News